Cargando…
Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model
AIM: To determine a dose response relationship of disintegration of a hyaluronic acid (HA) and hyaluronidase (HAS) used in prostate cancer radiotherapy. MATERIALS AND METHODS: Five in-vitro models are applicated with 3 ml (ml) HA. For dissolution varying doses of HAS were used: 6 ml, 3 ml, 1.5 ml, a...
Autores principales: | Vanneste, Ben G.L., Lutgens, Ludy, Van Limbergen, Evert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749177/ https://www.ncbi.nlm.nih.gov/pubmed/35036588 http://dx.doi.org/10.1016/j.ctro.2021.12.009 |
Ejemplares similares
-
A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn’s disease
por: Vanneste, Ben G.L., et al.
Publicado: (2018) -
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?
por: Vanneste, Ben G.L., et al.
Publicado: (2021) -
Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase
por: Buhren, Bettina Alexandra, et al.
Publicado: (2018) -
Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023) -
In Vitro Evaluation of the Sensitivity of a Hyaluronic Acid PEG Cross-Linked to Bovine Testes Hyaluronidase
por: Zerbinati, Nicola, et al.
Publicado: (2018)